Gan & Lee Pharmaceuticals Co., Ltd. Class ASSE: 603087

"Gan & Lee Pharmaceuticals"Announcement on Signing of the Authorization and License Agreement for the Bofanglutide Project with Menarini Group

Aug 11, 2026 · Issued by Gan & Lee Pharmaceuticals Co., Ltd. Class A via Shanghai Stock Exchange

Announcement on Signing of the Authorization and License Agreement for the Bofanglutide Project with Menarini Group

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

Earlier from Gan & Lee Pharmaceuticals Co., Ltd. Class A

"Gan & Lee Pharmaceuticals"Announcement on Implementation of Repurchase and Cancellation of Certain Restricted Shares under the 2022 and 2024 Restricted Share Incentive PlansAug 8
"Gan & Lee Pharmaceuticals."Announcement on Shareholding Reduction Plan by Directors and Senior ManagementAug 7
"Gan & Lee Pharmaceuticals."Announcement on Completion of Registration of the Grant under the 2026 Restricted Share Incentive PlanJul 29

All Gan & Lee Pharmaceuticals Co., Ltd. Class A news releases